The H19 Gene Imprinting in Normal Pregnancy and Pre-eclampsia

Placenta

Volumn 30, Issue 5, 2009, Pages 443-447

  Yu, L ^a   Chen, M ^a   Zhao, D ^a   Yi, P ^a   Lu, L ^a   Han, J ^a   Zheng, X ^a   Zhou, Y ^a   Li, L ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene imprinting; H19; Pre eclampsia; Pregnancy; Trophoblast

Indexed keywords

DNA; RNA H19;

ADULT; ALLELE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; FEMALE; GENE EXPRESSION; GENOME IMPRINTING; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HOSPITAL SERVICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SECOND TRIMESTER PREGNANCY; SYMPTOM; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; FEMALE; GENOMIC IMPRINTING; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED;

EID: 65049089188     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.02.011     Document Type: Article

References (35)

1. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
2. Lachmeijer A.M., Dekker G.A., Pals G., Aarnoudse J.G., ten-Kate L.P., and Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 105 (2002) 94-113
3. Chelbi S.T., and Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 282 (2008) 120-129
4. Gabory A., Ripoche M.A., Yoshimizu T., and Dandolo L. The H19 gene: regulation and function of a non-coding RNA. Cytogenet Genome Res 113 (2006) 188-193
5. Hurst L.D., and Smith N.G. Molecular evolutionary evidence that H19 RNA is functional. Trends Genet 15 (1999) 134-135
6. Rachmilewitz J., Gileadi O., Eldar-Geva T., Schneider T., de-Groot N., and Hochberg A. Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta. Mol Reprod Dev 32 (1992) 196-202
7. Wake N., Arima T., and Matsuda T. Involvement of IGF2 and H19 imprinting in choriocarcinoma development. Int J Gynecol Obstet 60 (1998) Sl-S8
8. Fowden A.L., Sibley C., Reik W., and Constancia M. Imprinted genes, placental development and fetal growth. Horm Res 65 (2006) S50-S58
9. Isles A.R., and Holland A.J. Imprinted genes and mother-offspring interactions. Early Hum Dev 81 (2005) 73-77
10. Isles A.R., and Wilkinson L.S. Imprinted genes, cognition and behaviour. Trends Cogn Sci 4 (2000) 309-318
11. Davies W., Isles A.R., and Wilkinson L.S. Imprinted genes and mental dysfunction. Ann Med 33 (2001) 428-436
12. Tycko B. Imprinted genes in placental growth and obstetric disorders. Cytogenet Genome Res 113 (2006) 271-278
13. Liou J.M., Wu M.S., Lin J.W., Wang H.P., Huang S.P., Chiu H.M., et al. Loss of imprinting of insulin-like growth factor II is associated with increased risk of proximal colon cancer. Eur J Cancer 43 (2007) 1276-1282
14. Guo L., Choufani S., Ferreira J., Smith A., Chitayat D., Shuman C., et al. Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev Biol 320 (2008) 79-91
15. Kim S.J., Park S.E., Chan L., Lee S.Y., Kim I.H., An H.J., et al. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases. Gynecol Oncol 88 (2003) 411-418
16. Visser M., Sijmons C., Bras J., Arceci R.J., Godfried M., Valentijn L.J., et al. Allelo type of pediatric rhabdomyosarcoma. Oncogene 15 (1997) 1503-1510
17. Bjornsson H.T., Brown L.J., Fallin M.D., Hans T., Rongione M.A., Bibikova M., et al. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst 99 (2007) 1270-1273
18. Lucifero D., Chailler J.R., and Trasler J.M. Potential significance of genomic imprinting defects for reproduction and assisted reproduction. Hum Reprod Update 10 (2004) 3-18
19. Pham N.V., Nguyen M.T., Hu J.F., Hu J.F., Vu T.H., and Hoffman A.R. Dissociation of IGF2 and H19 imprinting in human brain. Brain Res 810 (1998) 1-8
20. Walsh C., Miller S.J., Flam F., Fisher R.A., and Ohlsson R. Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast. Cancer Res 55 (1995) 1111-1119
21. Ariel I., Lustig O., Oyer C.E., Elkin M., Gonik B., Rachmilewitz J., et al. Relaxation of imprinting in trophoblastic disease. Gynecol Oncol 53 (1994) 212-219
22. Jinno Y., Ikeda Y., Yun K., Maw M., Masuzaki H., Fukuda H., et al. Establishment of functional imprinting of H19 gene in human developing placentae. Nat Genet 10 (1995) 318-324
23. Arima T., Matsuda T., and Takagi N. Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet 93 (1997) 39-47
24. Aparecida R.C., Pontes A., and Rogatto S.R. Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas. Gynecol Oncol 74 (1999) 375-380
25. Kim S.J., Park S.E., Chan L., Lee S.Y., Jo J.H., Kim J.M., et al. Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Biochim Biophys Acta 1586 (2002) 307-315
26. Merviel P., Carbillion L., Challier J.C., Rabreau M., Beaufils M., and Uzan S. Pathophysiology of preeclampsia: links with implantation disorders. Eur J Obstet Gynecol Reprod Biol 115 (2004) 134-147
27. Ayesh S., Matouk I., Schneider T., Ohana P., Laster M., Al-Sharef W., et al. Possible physiological role of H19 RNA. Mol Carcinog 35 (2002) 63-74
28. Egbor M., Ansari T., Morris N., Green C.J., and Sibbons P.D. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 113 (2006) 580-589
29. Hark A.T., Schoenherr C.J., Katz D.J., Ingram R.S., Levorse J.M., and Tilghman S.M. CTCF mediates methylation-sensitive enhancer-blocking activity at H19/Igf2 locus. Nature 405 (2000) 486-489
30. Constancia M., Kelsey G., and Reik W. Resourceful imprinting. Nature 432 (2004) 53-57
31. Jennifer A., and Marshall G. Genomic imprinting, development and disease-is pre-eclampsia caused by a maternally imprinted gene?. Reprod Fertil Dev 10 (1998) 23-29
32. Mutter W.P., and Karumanchi S.A. Molecular mechanisms of preeclampsia. Microvasc Res 75 (2008) 1-8
33. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion?. J Clin Invest 99 (1997) 2139-2151
34. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
35. Smets E.M.L., Visser A., Go A.T.J.I., van Vugt J.M.G., and Oudejans C.B.M. Novel biomarkers in preeclampsia. Clin Chim Acta 364 (2006) 22-32